Interações medicamentosas
Ado-trastuzumab + Trastuzumab deruxtecan
Gravidade: Grave
Ado-trastuzumab and Trastuzumab deruxtecan: major interaction.
Última atualização
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Resumo
Both are HER2-directed antibody-drug conjugates with cytotoxic payloads that cause myelosuppression, interstitial lung disease and cardiac toxicity. Combining them duplicates therapy and increases toxicity without established benefit.
O que esta interação significa em palavras simples
Ado-trastuzumab and Trastuzumab deruxtecan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Ado-trastuzumab belongs to Oncology; Trastuzumab deruxtecan belongs to Oncology.
Por que acontece
Additive cytotoxic, myelosuppressive and cardiopulmonary toxicity of two HER2-targeted antibody-drug conjugates.
O que fazer
Avoid concurrent use; they are not intended to be given together. Allow sequential use only with monitoring of blood counts, lung and cardiac function.
O que perguntar ao farmacêutico
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Ado-trastuzumab e Trastuzumab deruxtecan, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Experimente o Pro+ grátis por 14 dias na web. Sem cartão.
Outras interações de Ado-trastuzumab
Outras interações de Trastuzumab deruxtecan
Perguntas frequentes
Can I take Ado-trastuzumab with Trastuzumab deruxtecan?
MediHelp rates the interaction as major. Ado-trastuzumab and Trastuzumab deruxtecan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both are HER2-directed antibody-drug conjugates with cytotoxic payloads that cause myelosuppression, interstitial lung disease and cardiac toxicity. Combining them duplicates therapy and increases toxicity without established benefit.
How serious is the interaction between Ado-trastuzumab and Trastuzumab deruxtecan?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use; they are not intended to be given together. Allow sequential use only with monitoring of blood counts, lung and cardiac function.
What other medicines interact with Ado-trastuzumab?
MediHelp also lists interactions of Ado-trastuzumab with, for example, Atazanavir, Baricitinib, Ceritinib. The full list is on the Ado-trastuzumab page.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
